Literature DB >> 9006326

T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.

L Dianda1, A M Hanby, N A Wright, A Sebesteny, A C Hayday, M J Owen.   

Abstract

Mice with null mutations in cytokine or T cell receptor (TCR) genes develop intestinal inflammation. In the case of interleukin-2-/- and interleukin-10-/- mice it has been demonstrated that normal intestinal bacterial flora can cause gut pathology. TCR-alpha-/- mice not only develop colitis but also produce a strong antibody response to self-antigens, such as double-stranded DNA. It is therefore important to establish whether the intestinal inflammation develops spontaneously or is induced by luminal antigens. To address this issue, a germ-free colony of TCR-alpha-/- mice was derived and compared with TCR-alpha-/- mice kept in conventional specific-pathogen-free conditions. Although specific-pathogen-free animals developed colitis with a high level of penetrance, there was no evidence of intestinal pathology in germ-free animals. Furthermore, intestinal inflammation was not seen in TCR-alpha-/- mice colonized with a limited bacterial flora consisting of Lactobacillus plantarum, Streptococcus faecalis, S. faecium, and/or Escherichia coli. We conclude that intestinal inflammation in TCR-alpha-/- mice does not occur spontaneously nor does it result from the presence of bacteria, per se, but rather it is initiated by a specific organism or group of organisms normally present in the gut flora that have yet to be identified.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006326      PMCID: PMC1858528     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Germinal center formation in mice lacking alpha beta T cells.

Authors:  L Dianda; A Gulbranson-Judge; W Pao; A C Hayday; I C MacLennan; M J Owen
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

2.  T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice.

Authors:  A Ma; M Datta; E Margosian; J Chen; I Horak
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

3.  Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production.

Authors:  J M Klapproth; M S Donnenberg; J M Abraham; H L Mobley; S P James
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

4.  A gut-homing, oligoclonal CD4+ T cell population in severe-combined immunodeficient mice expressing a rearranged, transgenic class I-restricted alpha beta T cell receptor.

Authors:  J Reimann; A Rudolphi; S Spiess; M H Claesson
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

5.  Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis.

Authors:  S J Simpson; E Mizoguchi; D Allen; A K Bhan; C Terhorst
Journal:  Eur J Immunol       Date:  1995-09       Impact factor: 5.532

6.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

7.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

8.  Severe colitis in mice with aberrant thymic selection.

Authors:  G A Holländer; S J Simpson; E Mizoguchi; A Nichogiannopoulou; J She; J C Gutierrez-Ramos; A K Bhan; S J Burakoff; B Wang; C Terhorst
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

9.  Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.

Authors:  A Mizoguchi; E Mizoguchi; C Chiba; G M Spiekermann; S Tonegawa; C Nagler-Anderson; A K Bhan
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non alpha/beta" T cells.

Authors:  L Wen; W Pao; F S Wong; Q Peng; J Craft; B Zheng; G Kelsoe; L Dianda; M J Owen; A C Hayday
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  103 in total

Review 1.  The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Authors:  W Strober; K Nakamura; A Kitani
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

3.  Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.

Authors:  B Sheil; J MacSharry; L O'Callaghan; A O'Riordan; A Waters; J Morgan; J K Collins; L O'Mahony; F Shanahan
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

4.  Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.

Authors:  Katharine H Banner; Christophe Cattaneo; Jean-Loic Le Net; Aleksandar Popovic; David Collins; Jeremy D Gale
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

5.  Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine.

Authors:  Amlan Biswas; Jeanette Wilmanski; Huamei Forsman; Tomas Hrncir; Liming Hao; Helena Tlaskalova-Hogenova; Koichi S Kobayashi
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

6.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 7.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

8.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.

Authors:  Maria A Hahn; Torsten Hahn; Dong-Hyun Lee; R Steven Esworthy; Byung-Wook Kim; Arthur D Riggs; Fong-Fong Chu; Gerd P Pfeifer
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 10.  The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Authors:  Michael C Abt; David Artis
Journal:  Curr Opin Gastroenterol       Date:  2009-11       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.